INTRODUCTION
Pancreatitis is a rare but serious condition in pregnancy, occurring in fewer than 1 in 3000 deliveries. 1 Pancreatic pseudocysts complicate 5% of cases of pancreatitis, 2 or fewer than 1 in 60,000 deliveries, and the management of this rare condition is not standardized. We review available case reports of pancreatic pseudocysts in pregnancy 4 -17 and present one case which was managed conservatively but required splenectomy and distal pancreatectomy 3 weeks postpartum.
CASE REPORT
A 22-year-old black woman (gravida 3, aborta 2) at 26 weeks' gestation presented with a 3-day history of nausea, vomiting, and constant epigastric pain. She denied any prior history of such pain, or of biliary colic in the past. Her temperature was 100.68F, pulse rate was 84 beats/min, and blood pressure was 110/64 mm Hg. On examination, she was found to have a soft but distended abdomen with normal bowel sounds. Her WBC was 7600/mm 3 , amylase was 139 IU/dl, and lipase was 280 IU/dl; calcium, triglycerides, and liver function tests were normal. Ultrasonography demonstrated gallstones, a 7-mm dilated common bile duct, and a 6-cm fluid-filled cyst in the tail of the pancreas. MRI showed a well-encapsulated cyst in the tail of the pancreas medial to the spleen and adjacent to the greater curvature of the stomach. The patient declined drainage of the pseudocyst because of the potential risk of preterm labor, and was treated conservatively with bowel rest, intravenous fluids, and parenteral nutrition. Her pain resolved after 5 days, her diet was advanced after a week, and the patient was discharged after 2 weeks in the hospital. She developed preterm labor at 28 weeks that responded to tocolysis. The epigastric pain recurred at 36 weeks' gestation and again was managed conservatively. Sequential antepartum ultrasounds of the pseudocyst showed it to be enlarging to 10 cm as the pregnancy reached term. In an attempt to prevent pseudocyst rupture with Valsalva during labor, the patient was offered the option of assisted vaginal delivery with high-outlet forceps after complete cervical dilatation, which she declined in favor of elective cesarean delivery. At 37 weeks' gestation, a healthy, 2925-g male infant was delivered by low transverse cesarean section. Intraoperative laparoscopic exploration through the Pfannensteil incision revealed a 10Â12-cm pseudocyst with possible adhesion to the posterior wall of the stomach.
The patient recovered uneventfully after cesarean delivery and, 3 weeks later, underwent exploratory laparotomy and cholecystectomy. The pseudocyst had enlarged to 15 cm and was adherent not to the stomach but to the spleen. Splenectomy with distal pancreatectomy was performed. Pathology revealed a pseudocyst with surrounding pancreatic tissue demonstrating chronic pancreatitis; spleen and accessory spleen with splenic serosa showing fibrous adhesions and adherent pancreatic tissue; cholelithiasis; and mild chronic cholecystitis. The patient was discharged on postoperative day 5 and she and her baby continued to do well.
BACKGROUND:
Pancreatic pseudocyst in pregnancy is a rare condition whose management is not standardized.
STUDY DESIGN:
We combine one case report with nine others published in the literature since 1980. The cases are compiled to provide a descriptive review of this condition.
RESULTS:
The natural history of pancreatic pseudocysts in pregnancy appears similar to that in nongravid patients. Hyperlipidemia is overrepresented as a cause of pancreatic pseudocysts in pregnancy, causing more cases than alcoholic and biliary pancreatitis combined. Seventy -five percent of cases of known parity were primaparous. While in some cases percutaneous or endoscopic drainage was performed antepartum, most patients were conservatively managed until delivery. Despite two cases of successful vaginal delivery, cesarian section may be preferable for large pseudocysts to avert rupture. Perinatal/Neonatal Case Presentation 
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DISCUSSION
In nonpregnant patients, pancreatic pseudocysts are most frequently associated with alcoholic pancreatitis. The recommended management is to observe asymptomatic pseudocysts and those present for less than 6 weeks, as these have a 30% to 40% rate of spontaneous resolution. 2 Internal drainage is preferred for symptomatic cysts >5 cm diameter or those present for over 6 weeks, as these have a 3% chance of resolution and a 57% risk of rupture, infection, hemorrhage, or obstruction. 3 Internal drainage can be accomplished by anastomosis to the duodenum, a Roux-en-Y limb of jejunum, or the posterior wall of the stomach. When the pseudocyst is infected, located greater than 1 cm from bowel, or has a cyst wall insufficiently thick to permit anastomosis, percutaneous drainage can be considered despite a recurrence rate of 20% to 70% 3, 19 and the potential risks of infection 18 and fistulization. 19 Recently, endoscopy has been used to avert surgery in high-risk cases. 10 An indwelling transgastric or transduodenal pigtail catheter may be placed or a more permanent internal fistula created by cautery between the cyst and the adjacent viscus. This last procedure, while reportedly effective, carries a significant risk of bleeding and depends on the skill of the endoscopist. Endoscopic transpapillary stenting is another alternative for patients with a partial pancreatic duct disruption and a communicating pseudocyst. Limited information is available to guide the management of pancreatic pseudocysts in pregnancy. Many case reports of pancreatic pseudocysts occurring during pregnancy are limited by the lack of ultrasound measurements. Table 1 compiles the available information about presentation, etiology, management, and outcomes in these cases since 1980, when ultrasound, amylase, and lipase became widely available.
Six of the eight women of known gestation were primaparous. Alcohol was the etiology in less than a quarter of the cases. Gallstones, by far the commonest cause of pancreatitis during pregnancy, 1 accounted for only one case. Hyperlipidemia accounted for almost half of the cases. One patient was found to have Type I familial hyperlipoproteinemia, 16 and another Type V. 14 Two other cases were not fully diagnosed. 9, 12 Although their values are suggestive of Type V hyperlipoproteinemia, it would be unwise to presume the diagnosis because Type I may masquerade as Type V in times of stress. 14 The natural history of pancreatic pseudocysts appears similar to that in nongravid patients because pseudocysts less than 5 cm shrank or resolved while those greater than 5 cm remained the same size or enlarged. In three cases, intervention was performed antepartum: two patients underwent percutaneous drainage and one was stented endoscopically. Percutaneous drainage of one 6-cm cyst had an unspecified result; 17 another, of a 13-cm cyst at 24 weeks' gestation, showed initial relief of symptoms and reduction in cyst size with daily aspirations. However, in the latter case, the cyst subsequently collapsed around the drain, the cyst reaccumulated, and the patient had a preterm delivery. 15 One patient had a cystgastric stent placed with endoscopic retrograde cholangio-pancreatography at 17 weeks' gestation. In this case, the cyst shrank from 7 to 2 cm after the stent placement, but grew rapidly to 4 cm once the stent fell out. A transpapillary stent was then placed at 35 weeks' gestation, which stabilized the cyst until delivery at term. 10 Two cases of successful vaginal delivery were reported in women with 8-and 4-cm pseudocysts, 10,11 but our concern over the risks of Valsalva during labor seems warranted in light of one report of a pancreatic pseudocyst rupturing during vaginal delivery, causing hypotension and shock and necessitating intensive care.
14 With the exception of this case and our patient's splenectomy, all cases of morbidity reported in Table 1 resulted from pancreatitis or its underlying cause, rather than from the pseudocyst.
Cystic neoplasms are even less common than pancreatic pseudocysts, but can occur during pregnancy 20 -22 and may mimic inflammatory fluid collections. Especially notable is papillary cystic neoplasm, which occurs predominantly in young women and whose growth may be enhanced by progesterone. 21 Factors to help differentiate inflammatory from neoplastic fluid collections include: serum amylase level, which is elevated in 50% to 75% of pseudocysts 23 and 5% of pancreatic neoplasms; 19 cyst amylase level, which is normal in neoplasm and elevated in inflammatory fluid collections; ultrasonography demonstrating multiple cysts or internal septa that suggest neoplasm rather than inflammation; 23 and a history of pancreatitis or antecedent factors suggesting an inflammatory cause such as gallstones, hyperlipidemia, or alcoholism.
